Entera Bio Investor Relations Material
Latest events
Corporate Presentation
2 Jul, 2025
Q1 2025
9 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Entera Bio Ltd
Access all reports
Entera Bio Ltd. is a biotechnology company focused on the development of oral drug formulations for conditions traditionally treated with injectable therapies. The company specializes in proprietary oral delivery technology to improve the bioavailability of large molecules, such as peptides and proteins. Entera Bio’s research targets metabolic and endocrine disorders, including osteoporosis and hypoparathyroidism. The company is headquartered in Jerusalem, Israel, and its shares are listed on the NASDAQ.
Key slides for Entera Bio Ltd
Corporate Presentation
Entera Bio Ltd
Corporate Presentation
Entera Bio Ltd
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
ENTX
Country
🇺🇸 United States